Cargando…
APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is characterized by chronic relapsing inflammation of the gastrointestinal tract. The prevalence of IBD is increasing with approximately 4.9 million cases reported worldwide. Current therapies are limited due to the severity of side effects and long-term toxicity, th...
Autores principales: | Sahakian, Lauren, Robinson, Ainsley M., Sahakian, Linda, Stavely, Rhian, Kelley, Mark R., Nurgali, Kulmira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669584/ https://www.ncbi.nlm.nih.gov/pubmed/38002251 http://dx.doi.org/10.3390/biom13111569 |
Ejemplares similares
-
Oxidative Stress-Induced HMGB1 Translocation in Myenteric Neurons Contributes to Neuropathy in Colitis
por: Stavely, Rhian, et al.
Publicado: (2022) -
The emerging antioxidant paradigm of mesenchymal stem cell therapy
por: Stavely, Rhian, et al.
Publicado: (2020) -
Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
por: Craig, Colin F., et al.
Publicado: (2022) -
Human adult stem cells derived from adipose tissue and bone marrow attenuate enteric neuropathy in the guinea-pig model of acute colitis
por: Stavely, Rhian, et al.
Publicado: (2015) -
Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis
por: Stavely, Rhian, et al.
Publicado: (2015)